3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy

Therapy for Parkinson’s disease is quite challenging. Numerous drugs are available for symptomatic treatment, and levodopa (LD), in combination with a dopa decarboxylase inhibitor (e.g., benserazide (BZ)), has been the drug of choice for years. As the disease progresses, therapy must be supplemented...

Descripción completa

Detalles Bibliográficos
Autores principales: Windolf, Hellen, Chamberlain, Rebecca, Breitkreutz, Jörg, Quodbach, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145509/
https://www.ncbi.nlm.nih.gov/pubmed/35631518
http://dx.doi.org/10.3390/pharmaceutics14050931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145509/
https://www.ncbi.nlm.nih.gov/pubmed/35631518
http://dx.doi.org/10.3390/pharmaceutics14050931

Ejemplares similares